Apposite Capital, a London-based healthcare private equity investor, has acquired Health & Case Management (HCML), a rehabilitation and care management provider, and Crest Optics, an advanced microscope system maker. HealthInvestor For more information, chat with Apposite’s managing partner, Sam Gray.
The acquisition was in a pre-pandemic plan, Gray says.
Founded in 2003, HCML is one of the UK’s largest case management and treatment service providers specializing in physical and psychological rehabilitation. Based in Croydon, South London, we have an integrated network of over 1,000 physical and psychological providers.
“HCML is a well-received rehabilitation market, a differentiated innovation and growth agenda, and a dynamic, quality-focused team and platform,” Gray adds.
As part of the investment, HCML has appointed Nick Delaney as Chief Executive Officer. It is the former CEO of Ascenti, a physiotherapy and selected clinical outsourcing operator, has expanded its business more than five times over seven years of leadership and opened more than 400 sites.
Delaney said in a statement: operation. “
The terms of the transaction have not been disclosed.
The second acquisition of Apposite in November was the acquisition of Rome-based Crest Optics. The company was founded in 2010. Apposite currently has a majority share with the goal of accelerating global market penetration and launching new products.
The deal is supported by Xyence, an existing shareholder of Crest Optics, an Italian life sciences investor and partner of Crest Optics since 2018.
As part of the deal, Apposite introduced Dr. David Martyr, who will chair the board of directors of Crest Optics. Formerly Group President of Leica Microsystems and Chief Executive Officer of Tecan, David brings a wide range of industry experience.
Gray refuses to provide financial details for the transaction, but says Crest Optics is a fast-growing, profitable business and Life Sciences is an attractive and growing market.
“that [CrestOptics] Is a business that is on a rapid growth track, has a deep pipeline of innovations in new products, and is looking for investors to successfully bring these products to market. Apposite has a lot of experience and an excellent network in international life sciences. “
He concludes: “2021 was a record year for Apposite. We continue to see many interesting deals and opportunities. Apposite may make further investments in the coming months. Social care services , Apposite’s core sector. Currently, we are also focusing on the pharmaceutical industry. “
Release date: December 6, 2021
Subscribe today to get unlimited access
Are you already a subscriber? Login
Apposite Capital invests in HCML and Crest Optics
Source link Apposite Capital invests in HCML and Crest Optics